KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Other Accumulated Expenses (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Other Accumulated Expenses for 11 consecutive years, with $52.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses fell 1.49% year-over-year to $52.8 million, compared with a TTM value of $52.8 million through Dec 2025, down 1.49%, and an annual FY2025 reading of $52.8 million, down 1.49% over the prior year.
  • Other Accumulated Expenses was $52.8 million for Q4 2025 at Medpace Holdings, down from $54.3 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $62.5 million in Q1 2023 and bottomed at $9.2 million in Q2 2021.
  • Average Other Accumulated Expenses over 5 years is $37.3 million, with a median of $37.3 million recorded in 2024.
  • The sharpest move saw Other Accumulated Expenses plummeted 62.22% in 2022, then surged 574.48% in 2023.
  • Year by year, Other Accumulated Expenses stood at $27.6 million in 2021, then skyrocketed by 72.2% to $47.5 million in 2022, then decreased by 14.95% to $40.4 million in 2023, then skyrocketed by 32.62% to $53.6 million in 2024, then fell by 1.49% to $52.8 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for MEDP at $52.8 million in Q4 2025, $54.3 million in Q3 2025, and $44.9 million in Q2 2025.